Pere Gascón
Impact in
- Hematology top 0.5%
- Erythropoietin and Anemia Treatment
- Iron Metabolism and Disorders
- Oncology top 0.5%
- Neutropenia and Cancer Infections
- HER2/EGFR in Cancer Research
- Bone health and treatments
Papers in
- Hematology 41
- Erythropoietin and Anemia Treatment 35
- Iron Metabolism and Disorders 21
- Oncology 97
- Neutropenia and Cancer Infections 34
- Cancer Treatment and Pharmacology 13
- HER2/EGFR in Cancer Research 10
- Co-authors
- Heinz LudwigMatti AaproCarsten BokemeyerBegoña MelladoJoan AlbanellGunnar BirgegårdJosé BaselgaPeter Barrett‐Lee
- Journals
- Journal of Clinical Oncology (21 papers)Annals of Oncology (15 papers)Clinical & Translational Oncology (10 papers)Supportive Care in Cancer (9 papers)The Oncologist (7 papers)
- Partner nations
- SpainUnited StatesSwitzerland
In The Last Decade
Pere Gascón
158 papers receiving 5.6k citations
Hit Papers
Peers
Comparison fields: 5 of 133
- Hematology 1.3k
- Oncology 3.0k
- Biochemistry 330
- Otorhinolaryngology 234
- Genetics 462
Countries citing papers authored by Pere Gascón
This map shows the geographic impact of Pere Gascón's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pere Gascón with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pere Gascón more than expected).
Fields of papers citing papers by Pere Gascón
This network shows the impact of papers produced by Pere Gascón. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pere Gascón. The network helps show where Pere Gascón may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Pere Gascón, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2022 | 0 | |
| 3 | 2021 | 1 | |
| 4 | 2021 | 40 | |
| 5 | 2021 | 26 | |
| 6 | 2019 | 4 | |
| 7 | 2019 | 8 | |
| 8 | 2019 | 24 | |
| 9 | 2017 | 1 | |
| 10 | 2017 | 1 | |
| 11 | 2017 | 1 | |
| 12 | 2014 | 123 | |
| 13 | Anaemia and cancer: oral or intravenous iron? | 2012 | 1 |
| 14 | 2011 | 44 | |
| 15 | 2010 | 20 | |
| 16 | 2010 | 21 | |
| 17 | 2009 | 42 | |
| 18 | 2006 | 88 | |
| 19 | 2006 | 23 | |
| 20 | 2003 | 164 |
About Pere Gascón
Pere Gascón is a scholar working on Hematology, Oncology, Internal Medicine, Cancer Research and Biochemistry, having authored 163 papers that have together received 5.8k indexed citations. Recurring topics across this work include Erythropoietin and Anemia Treatment (35 papers), Neutropenia and Cancer Infections (34 papers), Iron Metabolism and Disorders (21 papers), Blood disorders and treatments (20 papers), Biosimilars and Bioanalytical Methods (19 papers), Cancer Treatment and Pharmacology (13 papers), HER2/EGFR in Cancer Research (10 papers) and Prostate Cancer Treatment and Research (10 papers). The work is most often cited by research in Hematology (1.3k citations), Oncology (3.0k citations), Biochemistry (330 citations), Otorhinolaryngology (234 citations) and Genetics (462 citations). Pere Gascón has collaborated with scholars based in Spain, United States and Switzerland. Frequent co-authors include Heinz Ludwig, Matti Aapro, Carsten Bokemeyer, Begoña Mellado, Joan Albanell, Gunnar Birgegård, José Baselga, Peter Barrett‐Lee, Dirk Schrijvers and M. Schneider. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Clinical & Translational Oncology, Supportive Care in Cancer and The Oncologist.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.